Perfromance Wealth Partners, LLC Revance Therapeutics, Inc. Transaction History

Perfromance Wealth Partners, LLC

  • $2.89 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024
BUY
$4.65 - $9.31 $76,725 - $153,615
16,500 New
16,500 $81,000
Q2 2023

Jul 13, 2023
BUY
$24.7 - $37.61 $74,100 - $112,830
3,000 Added 19.35%
18,500 $468,000
Q1 2023

Apr 20, 2023
BUY
$18.36 - $35.27 $45,900 - $88,175
2,500 Added 19.23%
15,500 $499,000
Q4 2021

Feb 03, 2022
BUY
$12.46 - $27.87 $161,980 - $362,310
13,000 New
13,000 $212,000

Others Institutions Holding RVNC

# of Institutions
232
Shares Held
82.1M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Perfromance Wealth Partners, LLC Portfolio

Follow Perfromance Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perfromance Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perfromance Wealth Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email